In this randomized controlled trial, in patients with both moderate-severe obstructive sleep apnea (OSA) and obesity, it was ...

,A weight-loss drug more effective than Ozempic and Wegovy has recently been approved in Australia. The drug, tirzepatide, is ...

On October 3, 2024, the US Food and Drug Administration (FDA) revised its shortage categorization of tirzepatide, a glucagon-like peptide 1 ...

Dame Andrea Jenkyns has criticised Government plans to use weight-loss jabs to get people back to work and boost the economy.

Tirzepatide for diabetes vs long-acting insulins demonstrated superior glycemic control and weight loss compared among adults with type 2 diabetes.

New research estimates that expanded access to Ozempic and similar drugs could lead to 42,000 deaths prevented annually.

Tirzepatide, a cutting-edge medication initially approved for the treatment of type 2 diabetes, has shown remarkable potential in facilitating significant weight loss. This dual GIP and GLP-1 receptor ...

The Government is considering using drugs to help get obese people back to work - but they can lead to serious health ...

The UK Government has signed a collaboration agreement with Lilly, the pharmaceutical giant behind weight loss medication ...

The Study is designed to measure tolerability and side effects, blood levels of tirzepatide, and blood glucose levels. The DehydraTECH-tirzepatide composition was formulated at a strength of 20 mg ...

These are essential to maximise the long-term effects of weight loss drugs. Without such improvement, the promotion of tirzepatide may actually have the effect of overwhelming services more. I am also ...